相关实验视频

Updated: Jul 19, 2025

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

基于人工智能的最佳治疗策略选择女性不孕症的第一个和随后的IVF-ET周期

Renjie Wang¹, Wei Pan², Lean Yu³

¹Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, PR China.

Journal of medical systems

|August 16, 2023

概括

中国中国中国中国.

科学领域:

生殖医学生殖医学
医疗保健中的人工智能
临床决策支持系统临床决策支持系统

背景情况:

中国不孕率上升 (12.5%-15%) 需要改进治疗策略.
试管受精和胚胎移植 (IVF-ET) 是至关重要的,但面临着成功率 (30%-40%) 和成本上升的挑战.
目前的IVF-ET治疗选择依赖于医生的经验,缺乏标准化的协议.

研究的目的:

开发基于人工智能 (AI) 的系统,以选择最佳的IVF-ET治疗策略.
通过数据驱动的决策来提高IVF-ET成功率并降低治疗成本.
根据患者个体特征提供个性化的治疗建议.

主要方法:

开发了一个人工智能系统来分析临床数据并模仿IVF-ET过程.
评估了十种不同的AI分类算法,以预测患者怀孕结果.
实施特征排名,以确定患者特征在治疗成功中的重要性.

主要成果:

在10个AI分类算法中,性能各不相同,这凸显了最佳方法选择的必要性.
功能排名确定了影响IVF-ET结果的关键患者特征.
人工智能系统展示了提高诊断准确性和治疗效率的潜力.

结论:

基于人工智能的方法可以有效地从临床数据中提取IVF-ET治疗选择的隐性知识.
选择最佳的人工智能算法对于在IVF-ET中准确预测怀孕至关重要.
基于患者特征的个性化治疗建议可以提高IVF-ET的结果和效率.

关键词:

人工智能分类算法AI分类算法功能排名功能排名试管婴儿-ETET,这是一个非常好的方法.不孕不育不孕不育不孕不育选择治疗策略,选择治疗策略.

更多相关视频

OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery

OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery

Published on: May 9, 2021

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Published on: March 25, 2021

相关概念视频

In Vitro Fertilization

In Vitro Fertilization

In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...

Infertility in Females

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...

Meiosis II

Meiosis II

Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each...

Infertility in Males

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...